Key result
Voltage-guided circumferential pulmonary vein ablation showed a non-significant trend toward lower atrial fibrillation recurrence compared to standard ablation (23% vs 39%, p=0.41).
Why the study?
Does voltage-guided circumferential pulmonary vein ablation improve acute and short-term outcomes in patients with paroxysmal atrial fibrillation?
Cohort (n=34)
No
Does voltage-guided circumferential pulmonary vein ablation improve acute and short-term outcomes in patients with paroxysmal atrial fibrillation?
Absolute Event Rate: 23% vs 39%
p-value: p=0.41
Voltage-guided circumferential pulmonary vein ablation may offer a trend toward reduced radiofrequency time compared to standard empirical ablation in patients with paroxysmal atrial fibrillation.
Voltage-guided ablation trends do not support practice change; leaves open benefit in paroxysmal AF pending randomized trials.
BACKGROUND: Ablation of the pulmonary vein (PV) antrum using an electroanatomic mapping system is standard of care for point-by-point pulmonary vein isolation (PVI). Focused ablation at critical areas is more likely to achieve intra-procedural PV isolation and decrease the likelihood for reconnection and recurrence of atrial fibrillation (AF). Therefore this prospective pilot study is to investigate the short-term outcome of a voltage-guided circumferential PV ablation (CPVA) strategy. METHODS: We recruited patients with a history of paroxysmal atrial fibrillation (AF). The EnSite NavX system (St. Jude Medical, St Paul, Minnesota, USA) was employed to construct a three-dimensional geometry of the left atrium (LA) and voltage map. CPVA was performed; with radiofrequency (RF) targeting sites of highest voltage first in a sequential clockwise fashion then followed by complete the gaps in circumferential ablation. Acute and short-term outcomes were compared to a control group undergoing conventional standard CPVA using the same 3D system. Follow-up was scheduled at 3, 6 and 12 months. RESULTS: Thirty-four paroxysmal AF patients with a mean age of 40 years were included. Fourteen patients (8 male) underwent voltage mapping and 20 patients underwent empirical, non-voltage guided standard CPVA. A mean of 54 ± 12 points per PV antrum were recorded. Mean voltage for right and left PVs antra were 1.7±0.1 mV and 1.9±0.2 mV, respectively. There was a trend towards reduced radiofrequency time (40.9±17.4 vs. 48.1±15.5 mins; p=0.22). CONCLUSION: Voltage-guided CPVA is a promising strategy in targeting critical points for PV isolation with a lower trend of AF recurrence compared with a standard CPVA in short-term period. Extended studies to confirm these findings are warranted.
No takes yet. Share an insight, caveat, or question.
Boles et al. (2017) conducted a cohort in Paroxysmal Atrial Fibrillation (n=34). Voltage-guided circumferential pulmonary vein ablation (CPVA) vs. Empirical, non-voltage guided standard CPVA was evaluated on Atrial fibrillation recurrence (p=0.41). Voltage-guided circumferential pulmonary vein ablation showed a non-significant trend toward lower atrial fibrillation recurrence compared to standard ablation (23% vs 39%, p=0.41).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: